7.44
price up icon5.83%   0.41
after-market 시간 외 거래: 7.55 0.11 +1.48%
loading
전일 마감가:
$7.03
열려 있는:
$7.05
하루 거래량:
917.85K
Relative Volume:
2.68
시가총액:
$598.35M
수익:
$36.90M
순이익/손실:
$-166.28M
주가수익비율:
-2.2614
EPS:
-3.29
순현금흐름:
$-203.53M
1주 성능:
+4.79%
1개월 성능:
-12.98%
6개월 성능:
-48.19%
1년 성능:
-62.44%
1일 변동 폭
Value
$6.935
$7.7374
1주일 범위
Value
$6.87
$7.7374
52주 변동 폭
Value
$6.10
$28.67

Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile

Name
명칭
Bicycle Therapeutics Plc Adr
Name
전화
011441223261503
Name
주소
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
Name
직원
305
Name
트위터
@Bicycle_tx
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
BCYC's Discussions on Twitter

BCYC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BCYC
Bicycle Therapeutics Plc Adr
7.44 598.35M 36.90M -166.28M -203.53M -3.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-08 개시 Stephens Equal-Weight
2024-09-06 개시 RBC Capital Mkts Outperform
2024-08-07 다운그레이드 B. Riley Securities Buy → Neutral
2023-09-11 업그레이드 B. Riley Securities Neutral → Buy
2022-08-31 개시 Cowen Outperform
2022-07-28 개시 Barclays Overweight
2022-07-06 재개 Canaccord Genuity Buy
2022-04-13 다운그레이드 B. Riley Securities Buy → Neutral
2022-04-07 재개 Cantor Fitzgerald Overweight
2022-02-14 개시 Morgan Stanley Equal-Weight
2021-12-17 개시 SVB Leerink Outperform
2021-12-09 개시 Needham Buy
2021-09-30 개시 B. Riley Securities Buy
2021-04-20 개시 JMP Securities Mkt Outperform
2020-10-12 개시 Cantor Fitzgerald Overweight
2020-06-12 개시 Oppenheimer Outperform
2020-04-17 개시 H.C. Wainwright Buy
2019-11-14 개시 ROTH Capital Buy
2019-09-11 업그레이드 Goldman Neutral → Buy
2019-06-17 개시 Canaccord Genuity Buy
2019-06-17 개시 Goldman Neutral
2019-06-17 개시 Jefferies Buy
2019-06-17 개시 Piper Jaffray Overweight
모두보기

Bicycle Therapeutics Plc Adr 주식(BCYC)의 최신 뉴스

pulisher
May 26, 2025

Bicycle Therapeutics’ SWOT analysis: stock faces pivotal phase amid clinical progress - Investing.com India

May 26, 2025
pulisher
May 07, 2025

Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 7.40 - DWinneX

May 07, 2025
pulisher
May 01, 2025

Bicycle Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com South Africa

May 01, 2025
pulisher
Apr 24, 2025

How should investors view Bicycle Therapeutics Plc ADR (BCYC)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

PBF Energy Inc [PBF] Records 50-Day SMA of $19.79 - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

UGI Corp [UGI] Records 200-Day SMA of $27.63 - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Cellebrite DI Ltd [NASDAQ: CLBT] Sees Increase in Stock Value - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.69 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading - MSN

Apr 23, 2025
pulisher
Apr 23, 2025

Bicycle Therapeutics Plc ADR Inc. (BCYC) Price Performance: The Role of Supply and Demand - investchronicle.com

Apr 23, 2025
pulisher
Apr 07, 2025

Fastenal Co (FAST) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 07, 2025
pulisher
Apr 05, 2025

Bicycle therapeutics CFO Alethia Young sells $1,724 in stock By Investing.com - Investing.com India

Apr 05, 2025
pulisher
Apr 04, 2025

Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle therapeutics COO Alistair Milnes sells $16,850 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle Therapeutics chief product officer sells shares worth $5,735 - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle Therapeutics CEO Lee Kevin sells shares worth $43,612 - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle Therapeutics chief accounting officer sells shares worth $2,499 - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle therapeutics CFO Alethia Young sells $1,724 in stock - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292 - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Bicycle Therapeutics chief accounting officer sells shares worth $2,499 By Investing.com - Investing.com UK

Apr 04, 2025
pulisher
Mar 31, 2025

Bicycle Therapeutics stock hits 52-week low at $8.6 amid downturn By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 27, 2025

Bicycle Therapeutics reshuffles leadership, aims for oncology advances By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Bicycle Therapeutics reshuffles leadership, aims for oncology advances - Investing.com India

Mar 27, 2025
pulisher
Mar 24, 2025

Bicycle Therapeutics stock hits 52-week low at $8.98 By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 12, 2025

Bicycle Therapeutics’ SWOT analysis: innovative platform drives stock potential - Investing.com India

Mar 12, 2025
pulisher
Mar 03, 2025

Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Mar 03, 2025
pulisher
Feb 25, 2025

Jefferies cuts Bicycle Therapeutics price target to $42 from $53 By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Bicycle Therapeutics stock holds $33 target, Buy rating at Rodman By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Mizuho maintains Harmony Biosciences $42 target, Outperform rating - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Mizuho maintains Harmony Biosciences $42 target, Outperform rating By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Jan 15, 2025

Bicycle Therapeutics' SWOT analysis: platform potential drives stock outlook - Investing.com India

Jan 15, 2025
pulisher
Jan 13, 2025

Bicycle Therapeutics reports promising cancer drug trial results - Investing.com India

Jan 13, 2025
pulisher
Jan 07, 2025

Bicycle therapeutics CDO Santiago Arroyo sells shares worth $69,646 - Investing.com India

Jan 07, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CFO Alethia Young sells shares totaling $19,655 - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics exec sells $30k in shares - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares By Investing.com - Investing.com South Africa

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CTO sells shares worth $60,119 By Investing.com - Investing.com South Africa

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 By Investing.com - Investing.com South Africa

Jan 06, 2025
pulisher
Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 - Investing.com India

Jan 06, 2025
pulisher
Dec 19, 2024

Bicycle Therapeutics' SWOT analysis: stock outlook amid clinical trials and cash strength - Investing.com India

Dec 19, 2024
pulisher
Nov 13, 2024

Bicycle Therapeutics' SWOT analysis: innovative platform fuels stock's potential - Investing.com

Nov 13, 2024
pulisher
Oct 23, 2024

Bicycle Therapeutics spotlights cancer treatment targets - Investing.com

Oct 23, 2024
pulisher
Oct 14, 2024

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - Yahoo Finance

Oct 14, 2024
pulisher
Oct 07, 2024

Oppenheimer backs Bicycle Therapeutics' BRC platform, reiterates $48 stock PT - Investing.com UK

Oct 07, 2024
pulisher
Oct 04, 2024

Bicycle therapeutics CEO sells shares worth over $71k - Investing.com

Oct 04, 2024
pulisher
Aug 10, 2024

Europe Peptide Drug Conjugates Market Size & Outlook, 2030 - Grand View Research

Aug 10, 2024
pulisher
Aug 09, 2024

What Makes Bicycle Therapeutics (BCYC) a New Buy Stock - Yahoo Finance

Aug 09, 2024
pulisher
Jul 14, 2024

South Korea Peptide Drug Conjugates Market Size & Outlook, 2030 - Grand View Research

Jul 14, 2024
pulisher
Jun 21, 2024

Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Yahoo Finance

Jun 21, 2024
pulisher
Jun 11, 2024

Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 11, 2024

Bicycle Therapeutics Plc Adr (BCYC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Bicycle Therapeutics Plc Adr 주식 (BCYC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Skynner Michael
CHIEF TECHNOLOGY OFFICER
Apr 03 '25
Sale
7.48
1,038
7,764
121,870
Skynner Michael
CHIEF TECHNOLOGY OFFICER
Apr 02 '25
Sale
8.02
814
6,528
122,908
Lee Kevin
CHIEF EXECUTIVE OFFICER
Apr 03 '25
Sale
7.48
3,432
25,671
486,265
Lee Kevin
CHIEF EXECUTIVE OFFICER
Apr 02 '25
Sale
8.02
2,237
17,941
489,697
Milnes Alistair
CHIEF OPERATING OFFICER
Apr 02 '25
Sale
8.02
1,133
9,087
98,655
Milnes Alistair
CHIEF OPERATING OFFICER
Apr 03 '25
Sale
7.48
1,038
7,764
97,617
Hannay Michael Charles Ferguso
CHIEF PROD & SUPPLY CHAIN OFF
Apr 02 '25
Sale
8.02
467
3,745
54,813
Hannay Michael Charles Ferguso
CHIEF PROD & SUPPLY CHAIN OFF
Apr 03 '25
Sale
7.48
266
1,990
54,547
Thompson Travis Alvin
CHIEF ACCOUNTING OFFICER
Apr 02 '25
Sale
8.02
210
1,684
31,936
Thompson Travis Alvin
CHIEF ACCOUNTING OFFICER
Apr 03 '25
Sale
7.48
109
815
31,827
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):